Moreover, a meta-analysis revealed that EPA supplementation decreased the circulating levels of adhesion molecules, including soluble ICAM-1 and soluble forms of vascular cell adhesion molecule (sVCAM)-1, both in participants with dyslipidemia and in healthy controls [29]. Here, ICAM1 is linked to metabolic syndrome.